{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:15:57Z","timestamp":1769105757811,"version":"3.49.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008494","name":"Vontobel Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008494","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.neurobiolaging.2024.03.007","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T16:18:50Z","timestamp":1711729130000},"page":"44-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Trajectories of amyloid beta accumulation \u2013 Unveiling the relationship with APOE genotype and cognitive decline"],"prefix":"10.1016","volume":"139","author":[{"given":"Maha","family":"Wybitul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Buchmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Hock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Treyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Gietl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neurobiolaging.2024.03.007_bib1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ana.21509","article-title":"Prodromal Alzheimer's disease: successive emergence of the clinical symptoms","volume":"64","author":"Amieva","year":"2008","journal-title":"Ann. Neurol.: Off. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"key":"10.1016\/j.neurobiolaging.2024.03.007_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.neurobiolaging.2016.02.016","article-title":"Association of genetic risk factors with cognitive decline: the PATH through life project","volume":"41","author":"Andrews","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2024.03.007_bib3","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jagp.2013.01.035","article-title":"Apolipoprotein E \u03b54 and later-life decline in cognitive function and grip strength","volume":"21","author":"Batterham","year":"2013","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2024.03.007_bib4","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2019.01.056","article-title":"A quarter century of APOE and Alzheimer\u2019s disease: progress to date and the path forward","volume":"101","author":"Belloy","year":"2019","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2024.03.007_bib5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nn.2801","article-title":"Neuronal activity regulates the regional vulnerability to amyloid-beta deposition.","volume":"14","author":"Bero","year":"2011","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2024.03.007_bib6","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1093\/brain\/awac213","article-title":"Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts","volume":"145","author":"Betthauser","year":"2022","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2024.03.007_bib7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/01.WNL.0000055875.26908.24","article-title":"The role of APOE-\u03b54 in longitudinal cognitive decline: MacArthur Studies of Successful Aging","volume":"60","author":"Bretsky","year":"2003","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2024.03.007_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/gerona\/glt103","article-title":"APOE genotype and cognitive change in young, middle-aged, and older adults living in the community","volume":"69","author":"Bunce","year":"2014","journal-title":"J. Gerontol. Ser. A: Biomed. Sci. Med. Sci."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.03.007_bib9","article-title":"Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals","volume":"13","author":"Collij","year":"2021","journal-title":"Alzheimer'S. Dement.: Diagn., Assess. Dis. Monit."},{"issue":"5123","key":"10.1016\/j.neurobiolaging.2024.03.007_bib10","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.neurobiolaging.2024.03.007_bib11","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.2017.6669","article-title":"Association between elevated brain amyloid and subsequent cognitive decline among cognitively normal persons","volume":"317","author":"Donohue","year":"2017","journal-title":"Jama"},{"key":"10.1016\/j.neurobiolaging.2024.03.007_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40035-018-0107-y","article-title":"Alzheimer's disease hypothesis and related therapies","volume":"7","author":"Du","year":"2018","journal-title":"Transl. Neurodegener."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2024.03.007_bib13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1037\/0894-4105.20.6.633","article-title":"Prospective memory and apolipoprotein E in healthy aging and early stage Alzheimer's disease","volume":"20","author":"Duchek","year":"2006","journal-title":"Neuropsychology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2024.03.007_bib14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1017\/S1041610209009405","article-title":"The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease","volume":"21","author":"Ellis","year":"2009","journal-title":"Int. Psychogeriatr."},{"issue":"19","key":"10.1016\/j.neurobiolaging.2024.03.007_bib15","doi-asserted-by":"crossref","first-page":"e1809","DOI":"10.1212\/WNL.0000000000006469","article-title":"Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults","volume":"91","author":"Farrell","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.03.007_bib16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.neuroimage.2010.08.009","article-title":"Differential effects of the APOE genotype on brain function across the lifespan","volume":"54","author":"Filippini","year":"2011","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2024.03.007_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2967\/jnumed.122.263948","article-title":"Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease","volume":"64","author":"Flores","year":"2023","journal-title":"J. Nucl. Med"},{"issue":"Pt 7","key":"10.1016\/j.neurobiolaging.2024.03.007_bib18","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1093\/brain\/awt127","article-title":"Lack of reliable evidence for a distinctive \u03b54-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study","volume":"136","author":"Foster","year":"2013","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2024.03.007_bib19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11065-014-9263-8","article-title":"Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan","volume":"24","author":"Fouquet","year":"2014","journal-title":"Neuropsychol. Rev."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2024.03.007_bib20","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.jalz.2018.05.013","article-title":"Rate of \u03b2-amyloid accumulation varies with baseline amyloid burden: Implications for anti-amyloid drug trials","volume":"14","author":"Guo","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"14","key":"10.1016\/j.neurobiolaging.2024.03.007_bib21","doi-asserted-by":"crossref","first-page":"e1512","DOI":"10.1212\/WNL.0000000000009216","article-title":"Detecting earlier stages of amyloid deposition using PET in cognitively normal elderly adults","volume":"94","author":"Guo","year":"2020","journal-title":"Neurology"},{"issue":"5580","key":"10.1016\/j.neurobiolaging.2024.03.007_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"5054","key":"10.1016\/j.neurobiolaging.2024.03.007_bib23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neurobiolaging.2024.03.007_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/2398212820961704","article-title":"Effect of apolipoprotein E polymorphism on cognition and brain in the Cambridge Centre for Ageing and Neuroscience cohort","volume":"4","author":"Henson","year":"2020","journal-title":"Brain Neurosci. Adv."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.03.007_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12929-019-0609-7","article-title":"Clinical trials of new drugs for Alzheimer disease","volume":"27","author":"Huang","year":"2020","journal-title":"J. Biomed. Sci."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2024.03.007_bib26","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1194\/jlr.R075481","article-title":"Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-beta and other amyloidogenic proteins","volume":"58","author":"Huynh","year":"2017","journal-title":"J. Lipid Res"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2024.03.007_bib27","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/acn3.51048","article-title":"The A4 study: \u03b2-amyloid and cognition in 4432 cognitively unimpaired adults","volume":"7","author":"Insel","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2024.03.007_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamaneurol.2020.3780","article-title":"Association Between Apolipoprotein E \u03b52 vs \u03b54, Age, and \u03b2-Amyloid in Adults Without Cognitive Impairment","volume":"78","author":"Insel","year":"2021","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2024.03.007_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.neurobiolaging.2024.03.007_bib30","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","article-title":"Brain beta-amyloid load approaches a plateau","volume":"80","author":"Jack","year":"2013","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2024.03.007_bib31","doi-asserted-by":"crossref","first-page":"e1347","DOI":"10.1212\/WNL.0000000000011524","article-title":"Temporal dynamics of \u03b2-amyloid accumulation in aging and Alzheimer disease","volume":"96","author":"Jagust","year":"2021","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2024.03.007_bib32","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/archgenpsychiatry.2010.30","article-title":"Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment","volume":"67","author":"Jessen","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2024.03.007_bib33","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archpsyc.61.5.518","article-title":"Apolipoprotein E \u03f54 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: the Cache County Study","volume":"61","author":"Khachaturian","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.03.007_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","article-title":"The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET","volume":"11","author":"Klunk","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2024.03.007_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jamaneurol.2020.3921","article-title":"Association of Initial \u03b2-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment","volume":"78","author":"Knopman","year":"2021","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.03.007_bib36","article-title":"Prediction of rapid amyloid and phosphorylated-Tau accumulation in cognitively healthy individuals","volume":"12","author":"Koychev","year":"2020","journal-title":"Alzheimers Dement (Amst."},{"issue":"17","key":"10.1016\/j.neurobiolaging.2024.03.007_bib37","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1212\/WNL.0000000000005354","article-title":"Memory decline accompanies subthreshold amyloid accumulation","volume":"90","author":"Landau","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2024.03.007_bib38","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ana.23650","article-title":"Amyloid deposition, hypometabolism, and longitudinal cognitive decline","volume":"72","author":"Landau","year":"2012","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.neurobiolaging.2024.03.007_bib39","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1212\/WNL.0000000000004336","article-title":"APOE genotype and early beta-amyloid accumulation in older adults without dementia","volume":"89","author":"Lim","year":"2017","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2024.03.007_bib40","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2024.03.007_bib41","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.3233\/JAD-150202","article-title":"Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline","volume":"48","author":"Lista","year":"2015","journal-title":"J. Alzheimer'S. Dis.: JAD"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.03.007_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1037\/a0026971","article-title":"Selecting a linear mixed model for longitudinal data: repeated measures analysis of variance, covariance pattern model, and growth curve approaches","volume":"17","author":"Liu","year":"2012","journal-title":"Psychol. Methods"},{"key":"10.1016\/j.neurobiolaging.2024.03.007_bib43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neurobiolaging.2020.05.012","article-title":"Influence of apolipoprotein-E genotype on brain amyloid load and longitudinal trajectories","volume":"94","author":"Lopresti","year":"2020","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2024.03.007_bib44","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/brain\/awu043","article-title":"Association of brain amyloid-\u03b2 with cerebral perfusion and structure in Alzheimer\u2019s disease and mild cognitive impairment","volume":"137","author":"Mattsson","year":"2014","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2024.03.007_bib45","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/ncn3.12107","article-title":"Cerebral blood flow abnormality in clinically diagnosed Alzheimer's disease patients with or without amyloid \u03b2 accumulation on positron emission tomography","volume":"5","author":"Mino","year":"2017","journal-title":"Neurol. Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2024.03.007_bib46","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/brain\/awy103","article-title":"Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE \u03b54 genotype","volume":"141","author":"Mishra","year":"2018","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2024.03.007_bib47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0895-4356(03)00007-6","article-title":"A comparison between traditional methods and multilevel regression for the analysis of multicenter intervention studies","volume":"56","author":"Moerbeek","year":"2003","journal-title":"J. Clin. Epidemiol."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2024.03.007_bib48","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jamaneurol.2014.2031","article-title":"Synergistic effect of \u03b2-amyloid and neurodegeneration on cognitive decline in clinically normal individuals","volume":"71","author":"Mormino","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.03.007_bib49","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.2307\/2533680","article-title":"Likelihood ratio testing of variance components in the linear mixed-effects model using restricted maximum likelihood","author":"Morrell","year":"1998","journal-title":"Biometrics"},{"key":"10.1016\/j.neurobiolaging.2024.03.007_bib50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fncel.2019.00181","article-title":"Phagocytosis of apoptotic cells is specifically upregulated in ApoE4 expressing microglia in vitro","volume":"13","author":"Muth","year":"2019","journal-title":"Front. Cell. Neurosci."},{"issue":"12","key":"10.1016\/j.neurobiolaging.2024.03.007_bib51","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.jalz.2018.06.1353","article-title":"Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale","volume":"14","author":"Navitsky","year":"2018","journal-title":"Alzheimer'S. Dement."},{"key":"10.1016\/j.neurobiolaging.2024.03.007_bib52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cortex.2018.03.025","article-title":"APOE genotype and cognition in healthy individuals at risk of Alzheimer's disease: A review","volume":"104","author":"O'Donoghue","year":"2018","journal-title":"cortex"},{"key":"10.1016\/j.neurobiolaging.2024.03.007_bib53","series-title":"Seminars in Immunology","article-title":"APOE mediated neuroinflammation and neurodegeneration in Alzheimer\u2019s disease","author":"Parhizkar","year":"2022"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2024.03.007_bib54","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.neurobiolaging.2015.04.001","article-title":"Changes in A\u03b2 biomarkers and associations with APOE genotype in 2 longitudinal cohorts","volume":"36","author":"Resnick","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.03.007_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-021-00836-1","article-title":"Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach","volume":"13","author":"Royse","year":"2021","journal-title":"Alzheimer'S. Res. Ther."},{"issue":"12","key":"10.1016\/j.neurobiolaging.2024.03.007_bib56","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.2967\/jnumed.119.238477","article-title":"Reshaping the amyloid buildup curve in Alzheimer Disease? Partial-volume effect correction of longitudinal amyloid PET data","volume":"61","author":"Rullmann","year":"2020","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.03.007_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-019-0478-z","article-title":"Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers","volume":"11","author":"Salvad\u00f3","year":"2019","journal-title":"Alzheimer'S. Res. Ther."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2024.03.007_bib58","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.03.007_bib59","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.dadm.2018.12.008","article-title":"Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies","volume":"11","author":"Su","year":"2019","journal-title":"Alzheimer'S. Dement.: Diagn., Assess. Dis. Monit."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.03.007_bib60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/archneurol.2009.913","article-title":"APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging","volume":"67","author":"Thambisetty","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neurobiolaging.2024.03.007_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.118440","article-title":"Relationships between \u03b2-amyloid and tau in an elderly population: An accelerated failure time model","volume":"242","author":"Therneau","year":"2021","journal-title":"Neuroimage"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2024.03.007_bib62","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/brain\/awx046","article-title":"Association between tau deposition and antecedent amyloid-\u03b2 accumulation rates in normal and early symptomatic individuals","volume":"140","author":"Tosun","year":"2017","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2024.03.007_bib63","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.20171265","article-title":"ApoE facilitates the microglial response to amyloid plaque pathology","volume":"215","author":"Ulrich","year":"2018","journal-title":"J. Exp. Med."},{"issue":"Pt 7","key":"10.1016\/j.neurobiolaging.2024.03.007_bib64","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/brain\/aws125","article-title":"Regional dynamics of amyloid-beta deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.","volume":"135","author":"Villain","year":"2012","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2024.03.007_bib65","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.03.007_bib66","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal assessment of A\u03b2 and cognition in aging and Alzheimer disease","volume":"69","author":"Villemagne","year":"2011","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.03.007_bib67","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11307-018-1219-6","article-title":"Spatial patterns of hypometabolism and amyloid deposition in variants of Alzheimer\u2019s disease corresponding to brain networks: a prospective cohort study","volume":"21","author":"Wang","year":"2019","journal-title":"Mol. Imaging Biol."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2024.03.007_bib68","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3233\/JAD-121897","article-title":"Interaction of age and APOE genotype on cerebral blood flow at rest","volume":"34","author":"Wierenga","year":"2013","journal-title":"J. Alzheimer'S. Dis.: JAD"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2024.03.007_bib69","first-page":"392","article-title":"Symbolic description of factorial models for analysis of variance","volume":"22","author":"Wilkinson","year":"1973","journal-title":"J. R. Stat. Soc. Ser. C: Appl. Stat."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.03.007_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-0358-9","article-title":"Therapeutic approaches targeting Apolipoprotein E function in Alzheimer\u2019s disease","volume":"15","author":"Williams","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2024.03.007_bib71","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopsych.2017.03.003","article-title":"Apolipoprotein E, receptors, and modulation of Alzheimer\u2019s disease","volume":"83","author":"Zhao","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2024.03.007_bib72","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s00018-017-2463-7","article-title":"Clearance of cerebral A\u03b2 in Alzheimer\u2019s disease: reassessing the role of microglia and monocytes","volume":"74","author":"Zuroff","year":"2017","journal-title":"Cell. Mol. Life Sci."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458024000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458024000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T09:27:13Z","timestamp":1717234033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458024000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":72,"alternative-id":["S0197458024000654"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2024.03.007","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trajectories of amyloid beta accumulation \u2013 Unveiling the relationship with APOE genotype and cognitive decline","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2024.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}